Antidepressant medication use for primary care patients with and without medical comorbidities: A national Electronic Health Record (EHR) network study

Journal of the American Board of Family Medicine

Volumn 23, Issue 4, 2010, Pages 499-508

  Gill, James M ^a,b,c   Klinkman, Michael S ^d   Chen, Ying Xia ^a  

^a Delaware Valley Outcomes Research   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c Via Christi Rehabilitation Center   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Chronic disease; Electronic medical records; PBRN; Practice based research; Primary health care

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ARTICLE; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; DEPRESSION; DIABETES MELLITUS; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIMARY MEDICAL CARE; ADULT; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CLINICAL PRACTICE; DEPRESSIVE DISORDER; DRUG UTILIZATION; ELECTRONIC MEDICAL RECORD; HEALTH SERVICES RESEARCH; MIDDLE AGED; NEOPLASMS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; ANTIDEPRESSIVE AGENTS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER; DIABETES MELLITUS; DRUG UTILIZATION; ELECTRONIC HEALTH RECORDS; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 77955300664     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2010.04.090299     Document Type: Article

References (55)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of- onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602. (Pubitemid 40973434)
2. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-27.
3. Klinkman MS, Okkes I. Mental health problems in primary care a research agenda. J Fam Pract 1998; 47:379-84. (Pubitemid 28541572)
4. Unutzer J, Katon W, Sullivan M, Miranda J. Treating depressed older adults in primary care: narrowing the gap between efficacy and effectiveness. Milbank Q 1999;77:225-56.
5. Katon W, Sullivan MD. Depression and chronic medical illness. J Clin Psychiatry 1990;51(Suppl):3-11; discussion, 12-4.
6. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002;25:464-70. (Pubitemid 41103337)
7. Whyte EM, Mulsant BH, Vanderbilt J, et al. Depression after stroke: a prospective epidemiological study. J Am Geriatr Soc 2004;52:774-8. (Pubitemid 38596498)
8. Guck TP, Kavan MG, Elsasser GN, Barone EJ. Assessment and treatment of depression following myocardial infarction. Am Fam Physician 2001;64: 641-8.
9. Ormel J, Von Korff M, Burger H, et al. Mental disorders among persons with heart disease - results from World Mental Health surveys. Gen Hosp Psychiatry 2007;29:325-34. (Pubitemid 47454644)
10. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008;118:1768-75.
11. Ziegelstein RC. Depression after myocardial infarction. Cardiol Rev 2001;9:45-51.
12. Patten SB, Williams JVA. Chronic obstructive lung diseases and prevalence of mood, anxiety, and substance- use disorders in a large population sample. Psychosomatics 2007;48:496-501.
13. Meyer HA, Sinnott C, Seed PT. Depressive symptoms in advanced cancer. Part 2. Depression over time; the role of the palliative care professional. Palliat Med 2003;17:604-7.
14. Massie M. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004;32:57-71.
15. Spiegel D. Cancer and depression. Br J Psychiatry Suppl 1996;(30):109-16.
16. Rush WA, Whitebird RR, Rush MR, Solberg LI, O'Connor PJ. Depression in patients with diabetes: does it impact clinical goals? J Am Board Fam Med 2008;21:392-7.
17. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005;28:1339-45. (Pubitemid 40756694)
18. Lin EHB, Heckbert SR, Rutter CM, et al. Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med 2009;7:414-21.
19. Lauzon C, Beck CA, Huynh T, et al. Depression and prognosis following hospital admission because of acute myocardial infarction [see comment]. CMAJ 2003;168:547-52.
20. Carney RM, Freedland KE, Steinmeyer B, et al. Depression and 5-year survival following acute myocardial infarction: a prospective study. J Affect Disord 2008;109:133-8.
21. Jia H, Damush TM, Qin H, et al. The impact of poststroke depression on healthcare use by veterans with acute stroke. Stroke 2006;37:2796-801.
22. Watson M, Haviland JS, Greer S, Davidson J, Bliss JM. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999;354:1331-6.
23. Smith GF, Toonen TR. Primary care of the patient with cancer. Am Fam Physician 2007;75:1207-14.
24. Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Int Med 2009;169:2128-39.
25. Gill JM, Chen YX, Lieberman MI. Management of depression in ambulatory care for patients with medical co-morbidities: a study from a national electronic health record (EHR) network. Int J Psychiatry Med 2008;38:203-15.
26. Gill J, Chen YX. Quality of lipid management in outpatient care: a national study using electronic health records. Am J Med Qual 2008;23:75-381.
27. Gill JM, Fleischut P, Haas S, Pellini B, Crawford A, Nash DB. Use of antibiotics for adult upper respiratory infections in outpatient settings: a national ambulatory network study. Fam Med 2006;38:349-54.
28. Gill JM, Foy AJ, Ling Y. Quality of outpatient care for diabetes mellitus in a national electronic health record network. Am J Med Qual 2006;21:13-7.
29. Gill JM, Chen YX, Glutting JJ, Diamond JJ, Lieberman MI. Impact of decision support in electronic medical records on lipid management in primary care. Popul Health Manag 2009;12:221-6.
30. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010;303:47-53.
31. Therapeutic Guidelines, Ltd. Therapeutic guidelines: psychotropic. 5 ed. North Melbourne: Therapeutic Guidelines, Ltd.; 2003.
32. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001;63:619-30.
33. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993;270:1819-25.
34. Morris PL, Robinson RG, Samuels J. Depression, introversion and mortality following stroke. Aust N J Z Psychiatry 1993;27:443-9.
35. Mohapatra PK, Kar N, Kar GC, Behera M. Effectiveness of sertraline in treatment of depression in a consecutive sample of patients with acute myocardial infarction: six-month prospective study on outcome. Clin Pract Epidemiol Ment Health 2005;1:26.
36. Taylor CB, Youngblood ME, Catellier D, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction [see comment]. Arch Gen Psychiatry 2005;62:792-8.
37. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial [see comment]. JAMA 2003;289:3106-16.
38. Jorge RE, Robinson RG, Arndt S, Starkstein S. Mortality and post-stroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 2003;160:1823-9.
39. Lustman P, Freedland K, Griffith L, Clouse R. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 2000;23:618-23.
40. Williams JW, Katon W, Lin EHB, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004;140:1015-24.
41. Lustman PJ, Griffith LS, Clouse RE, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997;59:241-50.
42. Thombs BDP, de Jonge PP, Coyne JCP, et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 2008;300: 2161-71.
43. Glassman AH, Roose SP, Bigger JT Jr. The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA 1993;269:2673-5.
44. Lespérance F, Frasure-Smith N, Kosyzcki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease. JAMA 2007;297:367-79.
45. Kharofa J, Sekar P, Haverbusch M, et al. Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke 2007;38:3049-51.
46. Bak S, Tsiropoulos I, Kjaersgaard JO, et al. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke 2002; 33:1465-73.
47. de Abajo FJ, Jick H, Derby L, Jick S, Schmitz S. Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol 2000; 50:43-7.
48. O'Connor CM, Jiang W, Kuchibhatla M, et al. Anti-depressant use, depression, and survival in patients with heart failure. Arch Intern Med 2008;168:2232-7.
49. Tata LJ, West J, Smith C, et al. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart 2005;91:465-71.
50. Klinkman MS. Competing demands in psychosocial care. A model for the identification and treatment of depressive disorders in primary care [see comment]. Gen Hosp Psychiatry 1997;19:98-111.
51. Rost K, Nutting P, Smith J, Coyne JC, Cooper- Patrick L, Rubenstein L. The role of competing demands in the treatment provided primary care patients with major depression. Arch Fam Med 2000; 9:150-4.
52. Nutting PA, Rost K, Smith J, Werner JJ, Elliot C. Competing demands from physical problems: effect on initiating and completing depression care over 6 months. Arch Fam Med 2000;9:1059-64.
53. Parchman ML, Pugh JA, Romero RL, Bowers KW. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med 2007;5:196-201.
54. Bayliss EA, Edwards AE, Steiner JF, Main DS. Processes of care desired by elderly patients with multimorbidities. Fam Pract 2008;25:287-93.
55. Lincoln NB, Flannaghan T. Cognitive behavioral psychotherapy for depression following stroke: a randomized controlled trial. Stroke 2003;34:111-5.